INFUSYSTEM HOLDINGS, INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INFUSYSTEM HOLDINGS, INC (INFU) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 916.53 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 916.53K shares, a 65.34% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.05M shares.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.55M shares, a 30.15% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.64M shares, a 37.95% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 490.43K shares, a 440.63% increase from fiscal 2016.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 90.72K shares, a 109.92% increase from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2015 was 43.22K shares, a 4.53% decline from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2014 was 45.27K shares, a 96.77% decline from fiscal 2013.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 916.53K shares 10-Q · filed 2026-08-04 | 1.16M shares 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | 1.05M shares 10-Q · filed 2026-05-08 | ||||
| 2025-09-30 | 1.55M shares 10-Q · filed 2025-11-04 | 2.18M shares 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 2.64M shares 10-Q · filed 2026-08-04 | 2.45M shares 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | ||||
| 2024-09-30 | 2.22M shares 10-Q · filed 2025-11-04 | 1.88M shares 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | 1.92M shares 10-Q · filed 2025-08-05 | 0.00 shares 10-Q · filed 2025-08-05 | 2.53M shares 10-Q · filed 2024-08-09 | ||
| 2023-09-30 | 1.07M shares 10-Q · filed 2024-11-08 | 912.83K shares 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | 902.00K shares 10-Q · filed 2024-08-09 | 755.23K shares 10-Q · filed 2024-08-09 | |||
| 2022-09-30 | 1.14M shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 100.00K shares 10-Q · filed 2022-08-04 | ||||
| 2021-09-30 | 300.00K shares 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | 200.00K shares 10-Q · filed 2022-08-04 | 100.00K shares 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 100.00K shares 10-Q · filed 2022-05-05 | ||||
| 2020-09-30 | 100.00K shares 10-Q · filed 2021-11-15 | 100.00K shares 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | 100.00K shares 10-Q · filed 2021-08-12 | 100.00K shares 10-Q · filed 2021-08-12 | |||
| 2019-09-30 | 100.00K shares 10-Q · filed 2020-11-13 | 100.00K shares 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | 100.00K shares 10-Q · filed 2020-08-14 | 100.00K shares 10-Q · filed 2020-08-14 | |||
| 2017-12-31 | 490.43K shares 10-K · filed 2018-03-19 | ||||
| 2016-12-31 | 90.72K shares 10-K · filed 2018-03-19 | ||||
| 2015-12-31 | 43.22K shares 10-K · filed 2017-03-22 | ||||
| 2014-12-31 | 45.27K shares 10-K/A · filed 2016-12-12 | ||||
| 2013-12-31 | 1.40M shares 10-K · filed 2014-03-11 | ||||
| 2012-12-31 | 300.00K shares 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |